Lars Erik Bryld

Lars Erik Bryld

Clinical Associate Professor

Member of:

  • Dermatovenerology


Publication year:
All
1 - 3 out of 3Page size: 10
  1. 2023
  2. Published

    Drug survival of adalimumab, secukinumab, and ustekinumab in psoriasis as determined by either dose escalation or drug discontinuation during the first 3 years of treatment - a nationwide cohort study

    Thein, D., Rosenø, N. A. L., Maul, J., Wu, J. J., Skov, Lone, Bryld, Lars Erik, Rasmussen, M. K., Ajgeiy, K. K., Thomsen, Simon Francis, Thyssen, Jacob Pontoppidan & Egeberg, Alexander, 2023, In: Journal of Investigative Dermatology. 143, 11, 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide Study

    Loft, N., Egeberg, Alexander, Isufi, D., Rasmussen, M. K., Bryld, Lars Erik, Dam, T. N., Ajgeiy, K. K., Bertelsen, T. & Skov, Lone, 2023, In: Acta Dermato-Venereologica. 103, 7 p., adv12616.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study

    Nielsen, M., Thein, D., Rasmussen, M. K., Bertelsen, T., Dam, T. N., Skov, Lone, Bryld, Lars Erik, Wu, J. J., Thomsen, Simon Francis, Thyssen, Jacob Pontoppidan & Egeberg, Alexander, 2023, In: Journal of the American Academy of Dermatology. 88, 6, p. 1378-1381 4 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

ID: 32369880